Videoconference-delivered psychotherapy for children and adolescents: A conceptual phase involving patients and their representatives in the planning and conceptualization of a clinical trial

Videoconference-delivered psychotherapy for children and adolescents: A conceptual phase involving patients and their representatives in the planning and conceptualization of a clinical trial - VIP-concept

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033667

Enrollment

124

Registered

2024-02-15

Start date

2024-02-19

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children and adolescents with experience in experience in outpatient psychotherapy, independent of current symptoms or need for treatment

Interventions

Group 1: Youth (11-18 years) with experience in outpatient psychotherapy and their parents (or caregivers) will be involved in the planning and conceptualization of a clinical trial evaluating videoco

Eligibility

Sex/Gender

All

Age

11 Years to 18 Years

Inclusion criteria

Inclusion criteria: experience with outpatient psychotherapy

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

Measure	Time frame
WP1: The relevance of research questions will be assessed with a self constructed questionnaire. WP2: Preferences and concerns regarding ethical and social challenges of the subsequent trial and barriers to patient recruitment are collected in self constructed, semi-structured interviews. WP3: The study design, patient-relevant endpoints, and a concept for the continuous involvement of the target group during the envisaged trial will be developed collaborately in a project working group. Consensus will be reached using the Delphi expert consensus method.	—

Measure

Time frame

WP1: The relevance of research questions will be assessed with a self constructed questionnaire. WP2: Preferences and concerns regarding ethical and social challenges of the subsequent trial and barriers to patient recruitment are collected in self constructed, semi-structured interviews. WP3: The study design, patient-relevant endpoints, and a concept for the continuous involvement of the target group during the envisaged trial will be developed collaborately in a project working group. Consensus will be reached using the Delphi expert consensus method.

—

Secondary

Measure	Time frame
Finalising the study design for a clinical trial	—

Countries

Germany

Contacts

Public ContactElena von Wirth

Ausbildungsinstitut für Kinder- und Jugendlichenpsychotherapie (AKiP) an der Uniklinik Köln

elena.von-wirth@uk-koeln.de+491738701848

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026